Translational research on reserve against neurodegenerative disease: consensus report of the International Conference on Cognitive Reserve in the Dementias and the Alzheimer's Association Reserve, Resilience and Protective Factors Professional Interest Area working groups.

Alzheimer’s disease Parkinson’s disease animal models biomarkers brain reserve cognitive reserve epidemiology neuroimaging prevention risk factors

Journal

BMC medicine
ISSN: 1741-7015
Titre abrégé: BMC Med
Pays: England
ID NLM: 101190723

Informations de publication

Date de publication:
27 02 2019
Historique:
received: 31 08 2018
accepted: 06 02 2019
entrez: 28 2 2019
pubmed: 28 2 2019
medline: 14 11 2019
Statut: epublish

Résumé

The concept of reserve was established to account for the observation that a given degree of neurodegenerative pathology may result in varying degrees of symptoms in different individuals. There is a large amount of evidence on epidemiological risk and protective factors for neurodegenerative diseases and dementia, yet the biological mechanisms that underpin the protective effects of certain lifestyle and physiological variables remain poorly understood, limiting the development of more effective preventive and treatment strategies. Additionally, different definitions and concepts of reserve exist, which hampers the coordination of research and comparison of results across studies. This paper represents the consensus of a multidisciplinary group of experts from different areas of research related to reserve, including clinical, epidemiological and basic sciences. The consensus was developed during meetings of the working groups of the first International Conference on Cognitive Reserve in the Dementias (24-25 November 2017, Munich, Germany) and the Alzheimer's Association Reserve and Resilience Professional Interest Area (25 July 2018, Chicago, USA). The main objective of the present paper is to develop a translational perspective on putative mechanisms underlying reserve against neurodegenerative disease, combining evidence from epidemiological and clinical studies with knowledge from animal and basic research. The potential brain functional and structural basis of reserve in Alzheimer's disease and other brain disorders are discussed, as well as relevant lifestyle and genetic factors assessed in both humans and animal models. There is an urgent need to advance our concept of reserve from a hypothetical model to a more concrete approach that can be used to improve the development of effective interventions aimed at preventing dementia. Our group recommends agreement on a common dictionary of terms referring to different aspects of reserve, the improvement of opportunities for data sharing across individual cohorts, harmonising research approaches across laboratories and groups to reduce heterogeneity associated with human data, global coordination of clinical trials to more effectively explore whether reducing epidemiological risk factors leads to a reduced burden of neurodegenerative diseases in the population, and an increase in our understanding of the appropriateness of animal models for reserve research.

Sections du résumé

BACKGROUND
The concept of reserve was established to account for the observation that a given degree of neurodegenerative pathology may result in varying degrees of symptoms in different individuals. There is a large amount of evidence on epidemiological risk and protective factors for neurodegenerative diseases and dementia, yet the biological mechanisms that underpin the protective effects of certain lifestyle and physiological variables remain poorly understood, limiting the development of more effective preventive and treatment strategies. Additionally, different definitions and concepts of reserve exist, which hampers the coordination of research and comparison of results across studies.
DISCUSSION
This paper represents the consensus of a multidisciplinary group of experts from different areas of research related to reserve, including clinical, epidemiological and basic sciences. The consensus was developed during meetings of the working groups of the first International Conference on Cognitive Reserve in the Dementias (24-25 November 2017, Munich, Germany) and the Alzheimer's Association Reserve and Resilience Professional Interest Area (25 July 2018, Chicago, USA). The main objective of the present paper is to develop a translational perspective on putative mechanisms underlying reserve against neurodegenerative disease, combining evidence from epidemiological and clinical studies with knowledge from animal and basic research. The potential brain functional and structural basis of reserve in Alzheimer's disease and other brain disorders are discussed, as well as relevant lifestyle and genetic factors assessed in both humans and animal models.
CONCLUSION
There is an urgent need to advance our concept of reserve from a hypothetical model to a more concrete approach that can be used to improve the development of effective interventions aimed at preventing dementia. Our group recommends agreement on a common dictionary of terms referring to different aspects of reserve, the improvement of opportunities for data sharing across individual cohorts, harmonising research approaches across laboratories and groups to reduce heterogeneity associated with human data, global coordination of clinical trials to more effectively explore whether reducing epidemiological risk factors leads to a reduced burden of neurodegenerative diseases in the population, and an increase in our understanding of the appropriateness of animal models for reserve research.

Identifiants

pubmed: 30808345
doi: 10.1186/s12916-019-1283-z
pii: 10.1186/s12916-019-1283-z
pmc: PMC6391801
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

47

Références

Int J Geriatr Psychiatry. 2007 Nov;22(11):1135-40
pubmed: 17479980
Cochrane Database Syst Rev. 2015 Apr 15;(4):CD006489
pubmed: 25874613
Psychol Aging. 1995 Dec;10(4):578-89
pubmed: 8749585
Cochrane Database Syst Rev. 2017 Apr 18;4:CD002854
pubmed: 28418065
Sci Rep. 2017 Aug 31;7(1):10160
pubmed: 28860449
Neurosci Biobehav Rev. 2014 Jun;43:48-73
pubmed: 24705269
J Neurol Sci. 2007 Jun 15;257(1-2):72-9
pubmed: 17303173
JAMA. 1994 Apr 6;271(13):1004-10
pubmed: 8139057
Alzheimers Dement. 2018 Apr;14(4):535-562
pubmed: 29653606
J Alzheimers Dis. 2012;28(1):137-46
pubmed: 21971406
Sci Rep. 2017 Jul 21;7(1):6136
pubmed: 28733627
Lancet Neurol. 2012 Nov;11(11):1006-12
pubmed: 23079557
Br J Gen Pract. 2015 Nov;65(640):567-8
pubmed: 26500299
Neurology. 2010 Jul 13;75(2):137-42
pubmed: 20625166
Lancet Neurol. 2011 Jan;10(1):31-42
pubmed: 21130037
Lancet Neurol. 2018 Nov;17(11):1006-1015
pubmed: 30244829
Trends Cogn Sci. 2010 Jul;14(7):325-37
pubmed: 20471301
J Neurol. 2007 Oct;254(10):1395-400
pubmed: 17934882
Neurology. 2002 Aug 13;59(3):364-70
pubmed: 12177369
Arch Intern Med. 2001 Jul 23;161(14):1703-8
pubmed: 11485502
J Neurosci. 2015 Jan 28;35(4):1781-91
pubmed: 25632151
Science. 2018 Jun 22;360(6395):
pubmed: 29930110
Science. 2012 Mar 9;335(6073):1238-42
pubmed: 22282476
Lancet. 2015 Jun 6;385(9984):2255-63
pubmed: 25771249
Neurobiol Aging. 2013 Feb;34(2):400-7
pubmed: 22626524
Zhonghua Yi Xue Za Zhi. 1999 May;79(5):335-8
pubmed: 11715471
Neuroepidemiology. 2015;45(4):237-54
pubmed: 26501691
J Int Neuropsychol Soc. 2016 Oct;22(9):920-927
pubmed: 27151620
Alzheimers Dement. 2018 Sep 14;:
pubmed: 30222945
Alzheimers Dement (Amst). 2017 May 31;7:107-114
pubmed: 28653033
J Clin Exp Neuropsychol. 2003 Aug;25(5):614-24
pubmed: 12815499
Brain. 2018 Apr 1;141(4):1186-1200
pubmed: 29462334
Cereb Cortex. 2017 Aug 1;27(8):3962-3969
pubmed: 27405332
Cold Spring Harb Perspect Med. 2011 Sep;1(1):a006189
pubmed: 22229116
Nat Rev Drug Discov. 2015 Mar;14(3):161-2
pubmed: 25722234
Dialogues Clin Neurosci. 2009;11(2):111-28
pubmed: 19585947
J Alzheimers Dis. 2012;28(1):11-24
pubmed: 22124029
Neuropsychology. 2015 Jul;29(4):649-57
pubmed: 25222199
Ann Epidemiol. 1993 Jan;3(1):71-7
pubmed: 8287159
Alzheimer Dis Assoc Disord. 2010 Apr-Jun;24(2):118-25
pubmed: 20505429
Neuroepidemiology. 1997;16(6):285-95
pubmed: 9430128
Neurology. 1995 Jun;45(6):1161-8
pubmed: 7783883
Med Sci Sports Exerc. 2001 May;33(5):772-7
pubmed: 11323547
Acta Psychiatr Scand. 1991 Feb;83(2):99-104
pubmed: 2017918
Am J Ind Med. 2003 Feb;43(2):204-11
pubmed: 12541276
Neurology. 2003 Sep 23;61(6):812-6
pubmed: 14504326
J Alzheimers Dis. 2018;64(1):71-78
pubmed: 29865075
Neuroimage. 2018 Sep;178:36-45
pubmed: 29772378
Lancet. 2013 Jun 8;381(9882):2016-23
pubmed: 23746902
Alzheimers Dement (N Y). 2018 May 03;4:195-214
pubmed: 29955663
Behav Genet. 1999 Nov;29(6):383-93
pubmed: 10857244
Front Neurosci. 2017 Nov 14;11:634
pubmed: 29184481
Arch Neurol. 2010 Jan;67(1):71-9
pubmed: 20065132
Psychol Aging. 1992 Mar;7(1):25-36
pubmed: 1558702
J Intern Med. 2011 Jan;269(1):107-17
pubmed: 20831630
Biol Psychiatry. 2012 May 1;71(9):783-91
pubmed: 22055015
Nat Commun. 2018 May 29;9(1):2098
pubmed: 29844566
Twin Res. 1999 Jun;2(2):88-98
pubmed: 10480743
Eur Neuropsychopharmacol. 2015 Feb;25(2):214-22
pubmed: 25172270
Arch Neurol. 2001 Mar;58(3):498-504
pubmed: 11255456
Arch Neurol. 1997 Nov;54(11):1399-405
pubmed: 9362989
Psychol Aging. 1995 Jun;10(2):294-303
pubmed: 7662188
Neurology. 2003 Jun 24;60(12):1909-15
pubmed: 12821732
Acta Neuropathol. 2017 Feb;133(2):155-175
pubmed: 28025715
J Alzheimers Dis. 2017;59(4):1381-1392
pubmed: 28731448
Alzheimers Dement. 2017 Jan;13(1):1-7
pubmed: 27583652
Neurology. 1995 Jan;45(1):55-60
pubmed: 7824135
Am J Epidemiol. 2002 Jun 15;155(12):1081-7
pubmed: 12048221
Neurology. 2013 Jul 30;81(5):417-26
pubmed: 23803317
Eur Neuropsychopharmacol. 2016 Oct;26(10):1638-48
pubmed: 27511320
Genet Epidemiol. 2013 Nov;37(7):643-57
pubmed: 24123198
Alzheimers Dement. 2019 Feb;15(2):273-281
pubmed: 30321503
Schizophr Res. 2013 Jan;143(1):125-31
pubmed: 23182439
Lancet. 2018 Apr 21;391(10130):1575
pubmed: 29695344
JAMA. 1996 Feb 21;275(7):528-32
pubmed: 8606473
Trends Neurosci. 2009 Apr;32(4):233-9
pubmed: 19268375
Neuropsychol Rev. 2014 Sep;24(3):355-70
pubmed: 25143069
J Clin Exp Neuropsychol. 2003 Aug;25(5):643-53
pubmed: 12815502
J Neurol Neurosurg Psychiatry. 2006 Sep;77(9):1060-3
pubmed: 16709580
Neurobiol Aging. 2011 Sep;32(9):1588-98
pubmed: 19926168
Lancet. 2018 Apr 21;391(10130):1574-1575
pubmed: 29695343
Environ Res. 2018 Oct;166:334-339
pubmed: 29909174
Mult Scler. 2019 Mar;25(3):372-381
pubmed: 29303036
PLoS One. 2012;7(6):e38268
pubmed: 22675535
Neuroimage. 2016 May 1;131:81-90
pubmed: 26477656
Mol Psychiatry. 2015 Feb;20(2):183-92
pubmed: 25644384
Child Dev. 1994 Apr;65(2 Spec No):296-318
pubmed: 7516849
Alzheimers Dement. 2013 Sep;9(5):580-6
pubmed: 23232272
Psychol Med. 1997 Nov;27(6):1337-44
pubmed: 9403905
Ann N Y Acad Sci. 2014 Jan;1307:82-88
pubmed: 23924195
Soc Sci Med. 2002 Sep;55(5):863-80
pubmed: 12190276
Cochrane Database Syst Rev. 2012 Feb 15;(2):CD005562
pubmed: 22336813
Trends Cogn Sci. 2012 May;16(5):292-305
pubmed: 22542563
Lancet Neurol. 2014 Jan;13(1):1
pubmed: 24291218
Int J Obes Relat Metab Disord. 1999 Apr;23 Suppl 3:S55-63
pubmed: 10368004
Cold Spring Harb Perspect Biol. 2015 Dec 18;8(2):a018986
pubmed: 26684183
Alzheimers Dement. 2017 Nov;13(11):1187-1196
pubmed: 28531379
Nat Rev Neurol. 2017 Jun;13(6):327-339
pubmed: 28497805
J Int Neuropsychol Soc. 2012 Nov;18(6):1081-5
pubmed: 23158231
Neurobiol Aging. 2012 May;33(5):1006.e25-36
pubmed: 22048124
Behav Genet. 1999 Nov;29(6):423-31
pubmed: 10857247
PLoS One. 2009;4(5):e5464
pubmed: 19421325
Acta Psychiatr Scand. 2016 May;133(5):386-98
pubmed: 26719018
Lancet. 2017 Dec 16;390(10113):2673-2734
pubmed: 28735855
Cortex. 2012 Sep;48(8):991-6
pubmed: 21596373
Ann Neurol. 1990 Apr;27(4):428-37
pubmed: 2353798
Am J Clin Nutr. 1999 Oct;70(4):456-65
pubmed: 10500013
Lancet. 2013 Oct 26;382(9902):1405-12
pubmed: 23871492
Lancet Neurol. 2017 Dec;16(12):965-975
pubmed: 29097166
Psychol Med. 2006 Apr;36(4):441-54
pubmed: 16207391
JAMA Neurol. 2014 Jan;71(1):11-22
pubmed: 24276092
Front Aging Neurosci. 2017 Aug 07;9:264
pubmed: 28824423
Dement Geriatr Cogn Disord. 2007;23(6):416-22
pubmed: 17457029
Twin Res. 1999 Jun;2(2):62-80
pubmed: 10480741
EBioMedicine. 2015 Aug 04;2(10):1420-9
pubmed: 26629536
Aging Ment Health. 2018 Aug;22(8):915-926
pubmed: 28703027
Neurology. 2013 Mar 26;80(13):1194-201
pubmed: 23486873
Neuroimage. 2013 Dec;83:450-7
pubmed: 23796547
Neurology. 2001 Dec 26;57(12):2236-42
pubmed: 11756603
Psychol Med. 1994 Feb;24(1):179-92
pubmed: 8208883
J Cogn Neurosci. 2013 Jan;25(1):29-36
pubmed: 23198888
Aging Ment Health. 2017 Nov;21(11):1113-1120
pubmed: 27827541
Brain Res. 2007 Feb 16;1133(1):178-85
pubmed: 17184752
Int J Epidemiol. 1994 Dec;23(6):1256-61
pubmed: 7721529
Neurology. 2002 Sep 24;59(6):887-93
pubmed: 12297572
Ann N Y Acad Sci. 2014 Jan;1307:89-103
pubmed: 24571182
Brain. 2018 Jul 1;141(7):2156-2166
pubmed: 29788038
J Hum Hypertens. 1997 Dec;11(12):777-81
pubmed: 9468003
Mult Scler. 2016 Jan;22(1):36-42
pubmed: 25921038
J Clin Exp Neuropsychol. 2003 Aug;25(5):680-90
pubmed: 12815505
Stroke. 2016 Jan;47(1):258-61
pubmed: 26585392
Nature. 2016 May 11;533(7604):539-42
pubmed: 27225129
Trends Neurosci. 2008 Apr;31(4):163-9
pubmed: 18329110
Eur J Nucl Med Mol Imaging. 2007 Jul;34(7):1082-7
pubmed: 17219132
J Am Geriatr Soc. 1995 May;43(5):485-90
pubmed: 7730528
Brain. 2017 Apr 1;140(4):1158-1165
pubmed: 28334888
Nat Genet. 2018 Jul;50(7):912-919
pubmed: 29942086
Alzheimers Dement. 2014 Mar;10(2):179-86
pubmed: 23706517
Neurology. 2013 May 14;80(20):1888-94
pubmed: 23596063
J Nucl Med. 2013 Jun;54(6):894-902
pubmed: 23591639
J Alzheimers Dis. 2017;58(1):45-54
pubmed: 28387680
Neurology. 2000 Nov 28;55(10):1455-9
pubmed: 11094097
Eur Psychiatry. 2012 Apr;27(3):219-22
pubmed: 21398096
Nat Genet. 2012 Apr 15;44(5):539-44
pubmed: 22504418
Alzheimers Dement. 2008 Sep;4(5):324-31
pubmed: 18790459
Prog Brain Res. 2002;138:109-33
pubmed: 12432766
Neuroimage. 2012 Aug 1;62(1):307-13
pubmed: 22542701
Nat Rev Neurosci. 2006 Sep;7(9):697-709
pubmed: 16924259
Psychol Aging. 1999 Jun;14(2):245-63
pubmed: 10403712
Lancet. 2000 Apr 15;355(9212):1315-9
pubmed: 10776744
Neurosci Biobehav Rev. 2016 Jun;65:208-28
pubmed: 27032724
Neurology. 2010 Nov 9;75(19):1726-9
pubmed: 21060095
Nat Neurosci. 2013 Sep;16(9):1348-55
pubmed: 23892552
Arch Neurol. 2001 Dec;58(12):2034-9
pubmed: 11735777
J Clin Epidemiol. 1994 Apr;47(4):363-74
pubmed: 7730861
Br J Psychiatry. 1968 Jul;114(512):797-811
pubmed: 5662937
Ann N Y Acad Sci. 2002 Nov;977:129-34
pubmed: 12480742
Psychol Aging. 2001 Sep;16(3):466-82
pubmed: 11554524
Methods Mol Biol. 2018;1750:15-29
pubmed: 29512063
Nat Rev Neurosci. 2018 Nov;19(11):701-710
pubmed: 30305711
Br J Prev Soc Med. 1976 Jun;30(2):101-6
pubmed: 986213
Neurology. 2013 Jun 11;80(24):2186-93
pubmed: 23667062
J Clin Exp Neuropsychol. 2015;37(3):253-64
pubmed: 25748936
Nat Neurosci. 2016 Dec;19(12):1569-1582
pubmed: 27694991
J Neurosci. 2012 Jun 27;32(26):8988-99
pubmed: 22745498
Neuroscientist. 2014 Dec;20(6):652-64
pubmed: 24622818
Cereb Cortex. 2005 Apr;15(4):394-402
pubmed: 15749983
Nat Rev Neurol. 2018 Nov;14(11):653-666
pubmed: 30291317
J Gerontol B Psychol Sci Soc Sci. 2003 Sep;58(5):P249-55
pubmed: 14507930
Mol Psychiatry. 2015 Dec;20(12):1588-95
pubmed: 25687773
Alzheimers Res Ther. 2018 Mar 6;10(1):28
pubmed: 29510747
J Clin Exp Neuropsychol. 2003 Aug;25(5):625-33
pubmed: 12815500
An Acad Bras Cienc. 2001 Jun;73(2):211-20
pubmed: 11404783
BMC Public Health. 2014 Jun 28;14:661
pubmed: 24972448
Alzheimers Dement. 2011 May;7(3):280-92
pubmed: 21514248
Alzheimers Res Ther. 2018 Jun 30;10(1):62
pubmed: 29960597
Neurology. 2008 Sep 30;71(14):1051-6
pubmed: 18579804
Neurology. 2017 Mar 14;88(11):1054-1061
pubmed: 28188306
Front Aging Neurosci. 2017 Nov 20;9:381
pubmed: 29209201
Acta Neuropathol. 2014 Jan;127(1):137-50
pubmed: 24356982

Auteurs

Robert Perneczky (R)

Division of Mental Health in Older Adults and Alzheimer Therapy and Research Center, Department of Psychiatry and Psychotherapy, University Hospital, Ludwig Maximilian University Munich, 80336, Munich, Germany. robert.perneczky@med.lmu.de.
German Center for Neurodegenerative Diseases (DZNE) Munich, Munich, Germany. robert.perneczky@med.lmu.de.
Ageing Epidemiology (AGE) Research Unit, School of Public Health, Imperial College London, London, UK. robert.perneczky@med.lmu.de.
Munich Cluster for Systems Neurology (SyNergy), Munich, Germany. robert.perneczky@med.lmu.de.

Gerd Kempermann (G)

German Center for Neurodegenerative Diseases (DZNE) Dresden, Dresden, Germany.
Center for Regenerative Therapies Dresden (CRTD), Technische Universität Dresden, Dresden, Germany.

Amos D Korczyn (AD)

Sackler School of Medicine, Tel- Aviv University, Ramat Aviv, Israel.

Fiona E Matthews (FE)

Institute of Health and Society, Newcastle University Institute for Ageing, Newcastle University, Newcastle, UK.
MRC Biostatistics Unit, Cambridge University, Cambridge, UK.

M Arfan Ikram (MA)

Department of Epidemiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.

Nikolaos Scarmeas (N)

Department of Social Medicine, Psychiatry and Neurology, 1st Department of Neurology, Aeginition University Hospital, National and Kapodistrian University of Athens, Athens, Greece.
Cognitive Neuroscience Division, Department of Neurology and The Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, NY, USA.

Gael Chetelat (G)

Université Normandie, Inserm, Université de Caen-Normandie, Inserm UMR-S U1237, GIP Cyceron, Caen, France.

Yaakov Stern (Y)

Cognitive Neuroscience Division, Department of Neurology and The Taub Institute for Research on Alzheimer's Disease and the Aging Brain, Columbia University Medical Center, New York, NY, USA.

Michael Ewers (M)

Institute for Stroke and Dementia Research, University Hospital, LMU Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH